Reaffirms FY25 adjusted EBITDA view $190M-$210M. Lowers FY25 capital expenditures view to ~$175M from ~$225 million in the previous guidance.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FRPT: